We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+7.7%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.67B
AUM Growth
+$240M
Cap. Flow
+$105M
Cap. Flow %
3.94%
Top 10 Hldgs %
17.98%
Holding
319
New
17
Increased
107
Reduced
57
Closed
13

Sector Composition

Rank Sector Weight
1 Technology 25.98%
2 Healthcare 19.42%
3 Industrials 19.08%
4 Consumer Discretionary 11.89%
5 Financials 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TUP
301
DELISTED
Tupperware Brands Corporation
TUP
$383K 0.01%
20,100
-10,300
-34% -$231K
CCMP
302
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$348K 0.01%
3,160
LTHM
303
DELISTED
Livent Corporation
LTHM
$234K 0.01%
33,763
-8,794
-21% -$79K
USA icon
304
Liberty All-Star Equity Fund
USA
$1.79B
$83K ﹤0.01%
13,000
IGD
305
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$511M
$77K ﹤0.01%
11,800
BGY icon
306
BlackRock Enhanced International Dividend Trust
BGY
$521M
$73K ﹤0.01%
13,000
AXON
307
Axon Enterprise
AXON
$42.3B
-12,200
Closed -$674K
CALM icon
308
Cal-Maine
CALM
$4.13B
-12,600
Closed -$545K
ESGR
309
DELISTED
Enstar Group
ESGR
-2,100
Closed -$367K
GIS icon
310
General Mills
GIS
$19.4B
-11,000
Closed -$561K
RAMP icon
311
LiveRamp
RAMP
$2.3B
-5,000
Closed -$274K
TDOC icon
312
Teladoc Health
TDOC
$1.19B
-18,000
Closed -$965K
THRM icon
313
Gentherm
THRM
$1.3B
-18,600
Closed -$708K
EPAY
314
DELISTED
Bottomline Technologies Inc
EPAY
-16,100
Closed -$813K
LDL
315
DELISTED
Lydall, Inc.
LDL
-15,600
Closed -$376K
MDSO
316
DELISTED
Medidata Solutions, Inc.
MDSO
-106,000
Closed -$7.95M
APC
317
DELISTED
Anadarko Petroleum
APC
-68,000
Closed -$3.13M
ULTI
318
DELISTED
Ultimate Software Group Inc
ULTI
-57,900
Closed -$19.1M
CELG
319
DELISTED
Celgene Corp
CELG
-245,000
Closed -$23M

Similar funds

EULAV Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, EULAV Asset Management held 319 positions worth $2.67B, up 9.9% from $2.43B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

EULAV Asset Management deployed $105M of net new capital in Q2 2019, opening 17 new positions and adding to 107 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 110,000 shares worth $4.82M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $5.33M trimmed.

  • EULAV Asset Management's largest Q2 2019 buy was Biohaven Pharmaceutical Holding Company Ltd.: 110,000 shares worth $4.82M.
  • EULAV Asset Management added most to Union Pacific in Q2 2019, an estimated $15M increase.
  • EULAV Asset Management's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $5.33M.
  • EULAV Asset Management fully exited Celgene Corp in Q2 2019, selling an estimated $23M.
  • EULAV Asset Management's ten largest holdings make up 18% of its $2.67B portfolio in Q2 2019.
  • EULAV Asset Management opened 17 new positions and closed 13 in Q2 2019.
  • EULAV Asset Management's portfolio value rose 9.9% quarter-over-quarter to $2.67B.

Based on EULAV Asset Management's 13F filing for Q2 2019, filed 5 Aug 2019.